| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/13/2006 | US20060153843 Method of immunomodulation |
| 07/13/2006 | US20060153842 Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection |
| 07/13/2006 | US20060153841 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | CA2594275A1 Method for preparation of lactic acid bacterium having anti-allergic activity |
| 07/13/2006 | CA2592614A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/13/2006 | CA2591138A1 Antibodies against antigen presenting cells and uses thereof |
| 07/13/2006 | CA2575248A1 Antibody vaccine conjugates and uses therefor |
| 07/12/2006 | EP1679320A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 07/12/2006 | EP1679081A2 Therapeutic application of cephaibols |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1678209A1 Antibodies to nik, their preparation and use |
| 07/12/2006 | EP1678180A1 Substituted 2h- 1,2,4 triazolo 4,3-a pyrazines as gsk-3 inhibitors |
| 07/12/2006 | EP1677814A1 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders |
| 07/12/2006 | EP1677782A2 Inhibitors of cathepsin s |
| 07/12/2006 | EP1506225B1 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1436321B1 Synthesis of cyclosporin analogs |
| 07/12/2006 | EP1427730B1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1150570B1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/12/2006 | EP1121439B1 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2006 | EP1071764B1 Antisense oligonucleotides for the inhibition of integrin alphav-subunit expression |
| 07/12/2006 | EP1037645B1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/12/2006 | EP0970114B1 Neoglycoproteins |
| 07/12/2006 | EP0900235B1 Fragments of cr1 and their use |
| 07/12/2006 | CN1802357A Aminopyrimidine derivatives and their medical use |
| 07/12/2006 | CN1802173A Packaged virus-like particles |
| 07/12/2006 | CN1802172A Therapeutic composition for autoimmune conditions |
| 07/12/2006 | CN1802166A Compositions for mucosal and oral administration comprising HCG fragments |
| 07/12/2006 | CN1800213A Peptides |
| 07/12/2006 | CN1800210A Compounds for treatment of infectious and immune system disorders and methods for their use |
| 07/12/2006 | CN1800175A Amino alcohol derivatives |
| 07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 07/12/2006 | CN1799554A Mannosan peptide injection and preparation method thereof |
| 07/12/2006 | CN1799394A Health-caring tea of sweet wormwood and its preparation |
| 07/12/2006 | CN1263763C Process for extracting ginkgolide |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263743C Therapeutic morpholino-substituted compounds |
| 07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
| 07/12/2006 | CN1263511C Live recombined vaccines injected with adjuvant |
| 07/12/2006 | CN1263510C Polysaccharide protein conjugate or oligosaccharide-protein conjugate, preparation method and application thereof |
| 07/12/2006 | CN1263469C Technique for preparing herbal medicine of seseli mairei Wolff |
| 07/12/2006 | CN1263468C Acellular short corynebacteria preparation |
| 07/12/2006 | CN1263461C Cell growth regulating factor F and its preparation process |
| 07/12/2006 | CN1263460C Cell growth regulating factor G and its preparation process |
| 07/12/2006 | CN1263459C Cell growth regulating factor O and its preparation process |
| 07/12/2006 | CN1263456C Medical preparation for parenteral administration |
| 07/12/2006 | CN1263389C Tea of whiteflower red root and producing method |
| 07/11/2006 | US7074925 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 07/11/2006 | US7074905 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2006 | US7074900 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
| 07/11/2006 | US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography |
| 07/11/2006 | US7074836 Para-terphenyl compounds |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074790 Antiinflammatory agents; autoimmune disease |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/11/2006 | US7074770 Administering to a mammal a vector or nucleotide sequence which code an antigenic peptide; together with Schiff base |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074617 MHC class II antigen-presenting systems and methods for activatind CD4+T cells |
| 07/11/2006 | US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies |
| 07/11/2006 | US7074411 α-β C4BP-type recombinant heteromultimeric proteins |
| 07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2293793C Rapamycin formulations for oral administration |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2168447C Compounds and methods for inhibition of hiv and related viruses |
| 07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/11/2006 | CA2078549C Multiple sclerosis t-cell receptor |
| 07/06/2006 | WO2006071819A1 [1h-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070891A1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 07/06/2006 | WO2006070874A1 Hypoxic response promoter |
| 07/06/2006 | WO2006070348A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY |
| 07/06/2006 | WO2006070325A2 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
| 07/06/2006 | WO2006070106A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/06/2006 | WO2006057900A3 17,20(z)-dehydro vitamin d analogs and their uses |
| 07/06/2006 | WO2006057899A3 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 07/06/2006 | WO2006024479A3 Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin |
| 07/06/2006 | WO2006000830A3 Cells expressing a modified t cell receptor |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060149066 Imidazole derivatives |
| 07/06/2006 | US20060149041 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060148901 Acylated 4-amidino-and-4-guanidinobenzylamines for inhibition of plasma kallikrein |
| 07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |